National Cancer Institute
Scope
Date
~
-
Bio & Pharma
S.Korea sees release of generic diabetes drugs after Forxiga patent expires
South Korea's pharmaceutical companies are competing to sell generic drugs to raise their presence on the domestic market for diabetes treatment wit...
Apr 11, 2023 (Gmt+09:00)
-
Bio & Pharma
JW Pharma to use zebrafish in new drug development
South Korean drug developer JW Pharmaceutical has entered into a memorandum of understanding (MOU) with Zefit, a domestic non-clinical trial institu...
Apr 10, 2023 (Gmt+09:00)
-
Bio & Pharma
Verismo's CAR-T therapy designated fast-track status by FDA
Verismo Therapeutics, a US affiliate of South Korean pharmaceutical firm HLB Co., has received fast-track designation from the US Food and Drug Admi...
Apr 07, 2023 (Gmt+09:00)
-
Economy
South Korea groans under snowballing national liabilities
South Korea’s liabilities ballooned last year following heavy fiscal spending related to the COVID-19 pandemic to buttress growth in Asia...
Apr 05, 2023 (Gmt+09:00)
-
Bio & Pharma
Lunit’s AI analysis solution client companies exceed 2,000
South Korean medical AI company Lunit announced on Tuesday that more than 2,000 medical institutions worldwide have adopted its AI-based diagnostic ...
Apr 04, 2023 (Gmt+09:00)
-
Business & Politics
Robot dog Spot joins in S.Korea’s World Expo bid efforts
Spot, a dog-like robot developed by South Korea’s top automaker Hyundai Motor-owned Boston Dynamics Inc., has joined in the country’s bi...
Apr 03, 2023 (Gmt+09:00)
-
Bio & Pharma
Kolon Pharma to merge with anti-cancer drug developer Platbio
Kolon Pharma, the pharmaceutical affiliate of South Korea's Kolon Group, is merging with anti-cancer drug developer Platbio to advance the developme...
Mar 30, 2023 (Gmt+09:00)
-
Tech, Media & Telecom
Korea's Hancom, Naver Cloud agree to cooperate in AI field
Hancom Inc. and Naver Cloud announced on Wednesday a strategic partnership to integrate Naver Cloud's large-scale artificial intelligence (AI) "Hype...
Mar 30, 2023 (Gmt+09:00)
-
COVID-19
S.Korea to cut COVID-19 quarantine from seven days to five in May
South Korea’s mandatory quarantine for confirmed COVID-19 patients from May will be cut from seven days to five, as the country is expected to...
Mar 30, 2023 (Gmt+09:00)
-
Banking & Finance
Clearstream acquires QFI status from S.Korea's National Tax Service
Korea Securities Depository announced on Wednesday that Clearstream, the operator of the International Central Securities Depository (ICSD), had obt...
Mar 29, 2023 (Gmt+09:00)
-
Energy
Korea Western Power lands nation's first solar power order in Oman
Korea Western Power Co. (KOWEPO) has won its country's first project in solar power generation in Oman.The company on Tuesday announced its successf...
Mar 22, 2023 (Gmt+09:00)
-
Bio & Pharma
Lunit's Insight DBT gets certification from EU for medical device
South Korean medical AI company Lunit said on Monday that its 3D breast tomosynthesis artificial intelligence (AI) image analysis solution, "Lunit I...
Mar 20, 2023 (Gmt+09:00)
-
Electric vehicles
Hyundai Motor, Kia to research EV energy with three universities
Hyundai Motor Co. and Kia Corp. will form a research ecosystem for sustainable electric vehicle (EV) energy with Seoul National University, Chung-An...
Mar 17, 2023 (Gmt+09:00)
-
Bio & Pharma
Prestige Bio's pancreatic cancer treatment gets US FDA fast-track designation
Prestige Biopharma, a biopharmaceutical company in South Korea, announced on Thursday that their pancreatic cancer antibody drug, PBP1510 (Ulenistam...
Mar 16, 2023 (Gmt+09:00)
-
Mergers & Acquisitions
HYBE kicks off campaign to win over SM shareholders
Bang Si-hyuk, founder and chairman of the BTS label HYBE Co., has kicked off his campaign to gather support from institutional investors to take con...
Mar 09, 2023 (Gmt+09:00)
-
Mergers & Acquisitions
HYBE barely ups SM stake in tender offer amid tensions with Kakao
HYBE Co. has raised its stake in the K-pop pioneer SM Entertainment Co. by merely 0.98% in a tender offer, after just one institution and minority i...
Mar 06, 2023 (Gmt+09:00)
-
Bio & Pharma
Korea's ST Pharm completes new R&D hub for gene therapy
ST Pharm Co., a South Korean drug raw material-producing subsidiary of Dong-A Socio Holdings, said on Friday that it has finished building an R&...
Mar 03, 2023 (Gmt+09:00)
-
Automobiles
S.Korea ranks fifth in global auto output for third straight year
South Korea’s auto production last year ranked fifth worldwide for the third year in a row.A report on world automotive output from the Korea ...
Mar 03, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion teams up with bio venture to develop new anti-cancer drug
South Korea's biopharmaceutical company Celltrion Inc. will develop an anti-cancer drug that combines oncolytic virus technology with biosimilars un...
Feb 28, 2023 (Gmt+09:00)
-
Bio & Pharma
SillaJen starts US trial of anti-cancer drug from Basilea
SillaJen Inc. said on Monday it has enrolled the first patient in a US phase 1 trial of an anti-cancer drug BAL0891 licensed from Swiss drugmaker Ba...
Feb 27, 2023 (Gmt+09:00)
-
Insurance
DB Insurance acquires Vietnam's 10th largest insurer VNI
DB Insurance has acquired Vietnam National Aviation Insurance (VNI), Vietnam's 10th-largest property and casualty(P&C) insurance company. With a...
Feb 24, 2023 (Gmt+09:00)
-
Korean stock market
S.Korean firms with focus on emerging Asia to shine
South Korean companies with a large proportion of sales to emerging Asia are expected to shine in the stock market this year as their revenue from t...
Feb 24, 2023 (Gmt+09:00)
-
Economy
AmCham pledges to make S.Korea Asia's top biz hub
The American Chamber of Commerce (AmCham) in South Korea on Thursday said it seeks to make the nation Asia's top business hub on the 70th anniversar...
Feb 23, 2023 (Gmt+09:00)
-
Hydrogen economy
Hyundai Heavy to develop core technology for seawater electrolysis system
Hyundai Heavy Industries Co. signed a business agreement for jointly developing seawater electrolysis system core technology at the Korea Institute ...
Feb 22, 2023 (Gmt+09:00)
-
Private equity
Korea's NPS, KTCU likely to invest in CVC's ninth buyout fund
South Korea’s key institutional investors are highly likely to invest via European private equity giant CVC Capital Partners’ ninth buyo...
Feb 20, 2023 (Gmt+09:00)
-
Bio & Pharma
Vaxcell-Bio, Cellid sign MOU to build cancer immunotherapy platform
Vaxcell-Bio Therapeutics, a South Korean company specializing in anti-cancer immunotherapy, announced on Wednesday its partnership with Cellid Co. t...
Feb 15, 2023 (Gmt+09:00)
-
Real estate
Zigbang signs agreement with Saudi's National Housing Company
On Monday, South Korean proptech company Zigbang announced a partnership with Saudi Arabia's National Housing Company with the goal of digitalizing ...
Feb 13, 2023 (Gmt+09:00)
-
Electronics
LG provides electronics service training to Cambodian youths
LG Electronics Inc. said on Sunday that it is offering technology training to help talented Cambodian youths become more self-reliant.For four days ...
Feb 13, 2023 (Gmt+09:00)
-
IPOs
Oasis IPO draws tepid interest from institutional investors
South Korean grocery delivery platform Oasis Corp. saw lukewarm interest from domestic institutional investors during the Feb. 7-8 bookbuilding for ...
Feb 09, 2023 (Gmt+09:00)
-
Artificial intelligence
S.Korea's Lunit supplies breast cancer imaging solution to UAE
South Korean medical AI company Lunit has supplied its breast cancer imaging analysis solution — Agfa HealthCare Enterprise Imaging — to...
Feb 09, 2023 (Gmt+09:00)
Latest News
- 1 Seoul appeal: Korean art captivates Indonesia’s affluent connoisseurs
- 2 CJ CheilJedang scraps $3.5 bn green bio sale, shifts gears to expansion
- 3 Trump Jr. meets Korean business chiefs in back-to-back sessions
- 4 Samsung in talks to supply customized HBM4 to Nvidia, Broadcom, Google
- 5 Kookmin Bank raises $700 mn in forex bonds amid strong demand